PET-CT

PET-CT combines positron emission tomography (PET) detectors and computed tomography (CT) into one imaging system. 

The Omni PET/CT platform accommodates patients across more care areas and offers a scalable design to easily enable future-ready capabilities and multi-dimensional scalability
News | PET-CT
GE Healthcare Introduces Omni Legend: A First-of-its-Kind All-Digital PET/CT System to Drive Efficiency, Enhance Diagnostics, and Deliver on Precision Medicine

October 17, 2022 — At the European Association of Nuclear Medicine (EANM) Annual Meeting, GE Healthcare proudly ...

Time October 17, 2022
arrow
Ground-breaking research funded by National Cancer Institute
News | PET-CT
Xoran Partners With WVU to Develop PET/CT Scanner for Head and Neck Cancers (HNCs)

September 28, 2022 — Xoran Technologies is engaged in a ground-breaking research project to develop a PET/CT scanner for ...

Time September 28, 2022
arrow
For over 40 years the vision of Shared Medical Services (SMS) has been to provide innovative imaging and service solutions to healthcare facilities regardless of their size, location or capital budget. That vision is as strong today as it was back in 1980.
News | PET-CT
SMS first to bring Mobile Digital PET/CT to North Dakota and Montana

September 13, 2022 — For over 40 years the vision of Shared Medical Services (SMS) has been to provide innovative ...

Time September 13, 2022
arrow
Societies Outline Recommendations for Hardware and Software, Training, Competency, Cross-specialty Collaboration, More
News | SPECT-CT
New ASNC-led Guideline Details How to Use CT in Hybrid Nuclear-CT Cardiac Imaging

September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to ...

Time September 07, 2022
arrow
NorthStar will provide Clovis with its environmentally preferred, high purity non-carrier-added (n.c.a.) Ac-225
News | PET Imaging
Independent Clinical Studies Published Regarding Performance of Axumin (Fluciclovine F 18) PET Imaging in Patients with Recurrent Prostate Cancer Undergoing Androgen Deprivation Therapy (ADT)

July 20, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 20, 2022
arrow
Radialis Inc. today announced that it has received clearance to market the Radialis PET Imager, an organ-targeted positron emission tomography (PET) system, in the United States
News | PET Imaging
Radialis PET Imaging Receives FDA Clearance

July 19, 2022 — Radialis Inc. today announced that it has received clearance to market the Radialis PET Imager, an organ ...

Time July 19, 2022
arrow
News | PET-CT
Aetna Reverses Cardiac PET/CT Non-coverage Policy

July 11, 2022 – The American Society of Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...

Time July 11, 2022
arrow
Lung cancer is the most common cancer in the world, with 2.2 million new cases and around 1.8 million deaths in 2020 alone
News | Lung Imaging
Lung Cancer: When Radiotherapy Fails

July 6, 2022 — Lung cancer is the most common cancer in the world, with 2.2 million new cases and around 1.8 million ...

Time July 06, 2022
arrow
Andrei Iagaru, MD, FACNM, Receives Inaugural SNMMI Sam Gambhir Trailblazer Award. Courtesy of SNMMI.
News | SNMMI
Andrei Iagaru, MD, FACNM, Receives Inaugural SNMMI Sam Gambhir Trailblazer Award

June 22, 2022 — Andrei Iagaru, MD, FACNM, professor of radiology (nuclear medicine) and chief of the Division of Nuclear ...

Time June 22, 2022
arrow
Representative case with acute anterior wall myocardial infarction: Myocardial perfusion images using 99mTc-tetrofosmin at rest (first row), 68Ga-FAPI-46 PET (second row), late gadolinium enhancement (LGE) from cardiac magnetic resonance (third row) and schematic drawings of the left ventricle (fourth row). Area of fibroblast activation exceeds infarct area and LGE signal, most common type of myocardial FAP-distribution. Bottom left: Mean areas of perfusion defect, FAPI-signal and LGE of 35 studied patients
News | PET Imaging
SNMMI Image of the Year: New Biomarker Predicts Severity of Cardiac Remodeling After Heart Attack

June 15, 2022 — Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68Ga-FAPI ...

Time June 15, 2022
arrow
Heat maps of PSMA PET prostatic fossa recurrence in patients with recurrence limited to the prostate fossa (miTr N0 M0, n=127), pelvic nodal disease (miTr N1 M0, n=30), distant organs/extra-pelvic nodal disease (miTr N0 M1, n=32) and pelvic nodal plus distant organs/extra-pelvic nodal disease (miTr N1 M1, n=37). The yellow contour represents the RTOG CTV
News | Prostate Cancer
PSMA PET Highlights Need for Updated Prostate Cancer Therapy Guidelines

June 15, 2022 — Current guidelines used to plan salvage radiation treatments in patients with local recurrence of ...

Time June 15, 2022
arrow
Representative axial image from a test set imaging study. From top left to bottom right: CT (A), NAC-PET (B), original AC-PET (C), AI-generated AC-PET (D). The blue arrow indicates one lesion that was observed in both images, and the red arrow indicates a lesion that was missed (i.e., not de-tected by expert nuclear medicine physicians) in AI image. NAC = Non-Attenuation Corrected. AC = Attenuation-Corrected
News | PET-CT
Virtual CT Scans Cut Patient Radiation Exposure in Half During PET/CT Studies

June 14, 2022 — A novel artificial intelligence method can be used to generate high-quality “PET/CT” images and ...

Time June 14, 2022
arrow
At the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2022 Annual Meeting, GE Healthcare showcases cutting-edge solutions spanning the care continuum and enabling theranostics in prostate cancer
News | Prostate Cancer
GE Healthcare’s Total Molecular Imaging Solutions Enable Precision Health and Theranostics for Personalized Prostate Cancer Care

June 10, 2022 — GE Healthcare provides cutting-edge molecular imaging solutions that enable and increase access to ...

Time June 10, 2022
arrow
The ACR Committee on Drugs and Contrast Media, within the ACR Commission on Quality and Safety, is aware of the current global shortage of iodinated contrast media.
News | Contrast Media
Statement from the ACR Committee on Drugs and Contrast Media

May 13, 2022 — The ACR Committee on Drugs and Contrast Media, within the ACR Commission on Quality and Safety, is aware ...

Time May 13, 2022
arrow
Prof. Dr. Samer Ezziddin, image courtesy of Thorsten Mohr/Saarland University
News | Prostate Cancer
New Radiotracer Yields Huge Increase in Accuracy of Localizing Prostate Cancer relapses

April 15, 2022 — Prostate cancer is the most common malignant tumor in men in Germany, with about 62,000 new cases ...

Time April 14, 2022
arrow
Quantitative analysis of pre-treatment PSMA PET/CT in a patient undergoing treatment with ¹⁷⁷Lutetium-PSMA-617/NOX66. Post-treatment PSMA PET/CT demonstrates reduced tumor volume and PSMA intensity. Images created by S Pathmanandavel and L Emmett, St Vincent's Hospital, Sydney, Australia.
News | PET-CT
New Radionuclide Combination Therapy Safe and Effective in Metastatic Prostate Cancer Patients

April 11, 2022 — A novel nuclear medicine combination therapy has been proven safe and effective in men with heavily pre ...

Time April 11, 2022
arrow
Surge in demand for the effective diagnostic system, technological advancements, and increase in the prevalence of diseases have boosted the growth of the global PET-CT scanner device market
News | PET-CT
Global PET-CT Scanner Device Market to Hit $3.20 Billion by 2030

February 23, 2022 — Surge in demand for the effective diagnostic system, technological advancements, and increase in the ...

Time February 23, 2022
arrow
The global PET-CT scanner device market size is expected to reach USD 3.34 billion by 2028 according to a new study by Polaris Market Research.
News | PET-CT
PET-CT Scanner Device Market Size Worth $3.34 Billion By 2028

February 15, 2022 — The global PET-CT scanner device market size is expected to reach USD 3.34 billion by 2028 according ...

Time February 15, 2022
arrow
The Task Force members have recently observed an unusual imaging pattern on FDG PET/CT or FDG PET/MR that may be due to COVID-19 infection. 
News | Coronavirus (COVID-19)
SNMMI Task Force Reports Possible Effect of Omicron Infection on FDG PET/CT Scans

January 17, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) issued a statement on Jan. 14 regarding ...

Time January 17, 2022
arrow
Case examples of quantitative plaque analysis on coronary CT angiography and 18F-NaF PET in patients with established coronary artery disease. Hybrid CT angiography and 18F-NaF PET of coronary arteries. (A) A 70-y-old male, who presented with diffused largely noncalcified disease (middle panel in red) in the LAD and demonstrated increased 18F-NaF uptake in the LAD on PET. (B) A 59-y-old male with mild LCX atherosclerosis, who presented with a high noncalcified plaque burden (middle panel in red) on CT angio
News | PET-CT
PET/CT Artificial Intelligence Model Ideal for Predicting Risk of Future Heart Attack

January 12, 2022 — By combining information from two advanced imaging techniques with clinical data, physicians can ...

Time January 12, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now